Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nira Arad-Cohen, Bernward Zeller, Jonas Abrahamsson, Jose Maria Fernandez Navarro, Daniel Cheuk, Sauli Palmu, Vitor Costa, Barbara De Moerloose, Henrik Hasle, Kirsi Jahnukainen, Cornelis Jan Pronk, Ólafur Gísli Jónsson, Zhanna Kovalova, Birgitte Lausen, Monica Munthe-Kaas, Ulrika Noren-Nyström, Josefine Palle, Ramune Pasauliene, Kadri Saks & Gertjan JL Kaspers. (2022) Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium. Expert Review of Anticancer Therapy 22:11, pages 1183-1196.
Read now
Read now
Zahra Taherimehr, Maryam Zaboli & Masoud Torkzadeh-Mahani. (2022) New insight into the molecular mechanism of the trehalose effect on urate oxidase stability. Journal of Biomolecular Structure and Dynamics 40:4, pages 1461-1471.
Read now
Read now
Shaoyan Hu, Yi Han, Wenjie Zhang, Tianxiang Zhang, Xingxing Yao & Li Liu. (2019) Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China. Journal of Medical Economics 22:8, pages 742-750.
Read now
Read now
Larysa Strilchuk, Federica Fogacci & Arrigo Fg Cicero. (2019) Safety and tolerability of available urate-lowering drugs: a critical review. Expert Opinion on Drug Safety 18:4, pages 261-271.
Read now
Read now
Articles from other publishers (54)
Erika Biró, Dániel Erdélyi, Petra Varga, Mária Sinkó, Katalin Bartyik, Gábor Kovács, Gábor Ottóffy, Ferenc Vincze, István Szegedi, Csongor Kiss & Tamás Szabó. (2023) Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome. Pediatric Nephrology 38:9, pages 3117-3127.
Crossref
Crossref
Tianyou Wang, Xiaofan Zhu, Yumei Chen, Shuhong Shen, Yongmin Tang, Jingying Zhang, Yingyi He, Hui Zhang, Ju Gao, Jianpei Fang, Rong Liu, Xiaoyan Wu, Jinchuan Sun & Minlu Zhang. (2023) Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study. Drugs in R&D 23:2, pages 129-140.
Crossref
Crossref
Annalisa Noce, Giulia Marrone, Manuela Di Lauro, Anna Paola Mitterhofer, Maria Josè Ceravolo, Nicola Di Daniele, Guglielmo Manenti & Antonino De Lorenzo. (2023) The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage. Cancers 15:8, pages 2254.
Crossref
Crossref
Su Kyung Lee, Min Jung Geum, Jong Hee Ko, Eun Sun Son & Yun Mi Yu. (2023) Use of Prophylactic Drugs according to Risk Classification for TLS in Patients with Hematological Malignancies. Journal of Korean Society of Health-System Pharmacists 40:1, pages 59-71.
Crossref
Crossref
Robert Chapman, Sita Shah & Alberto D’Angelo. (2022) Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care. Journal of the Intensive Care Society 24:1, pages 112-116.
Crossref
Crossref
Yoshihiro Mouri, Manabu Natsumeda, Noritaka Okubo, Taro Sato, Taiki Saito, Kohei Shibuya, Shiori Yamada, Jotaro On, Yoshihiro Tsukamoto, Masayasu Okada, Makoto Oishi, Takeyoshi Eda, Junko Murai, Hiroshi Shimizu, Akiyoshi Kakita & Yukihiko Fujii. (2022) Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report. Journal of Clinical Medicine 11:19, pages 5548.
Crossref
Crossref
Kerry A RogersXiaoxiao LuBruno EmondAurélie Côté-SergentFrédéric KinkeadMarie-Hélène LafeuillePatrick LefebvreQing Huang. (2022) Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study. Journal of Managed Care & Specialty Pharmacy 28:9, pages 1033-1045.
Crossref
Crossref
Amineh Mashkoori, Ali Mostafavi, Tayebeh Shamspur & Masoud Torkzadeh-Mahani. (2022) Electrochemical enzyme-based blood uric acid biosensor: new insight into the enzyme immobilization on the surface of electrode via poly-histidine tag. Microchimica Acta 189:9.
Crossref
Crossref
Hossein Bonakchi, Bentolhoda Kuhestani Dehaghi, Fatemeh Sadat Hosseini-Baharanchi, Sayeh Parkhideh, Hamid Farhangi & Ahmad reza baghestani. (2022) A New and Cost-Effective Approach to Risk Stratification for Children with Precursor B-Cell Acute Lymphoblastic Leukemia Based on Competing Outcomes. Iranian Journal of Pediatrics 32:4.
Crossref
Crossref
Ella Mae I. Masamayor, John Jefferson V. Besa, Carol Stephanie C. Tan-Lim, A. Nico Nahar I. Pajes & Lia M. Palileo-Villanueva. (2022) Effectiveness and Safety of Allopurinol, Febuxostat, and Rasburicase in the Prevention of Tumor Lysis Syndrome: A Systematic Review and Network Meta-analysis. Asian Journal of Oncology.
Crossref
Crossref
Man-man Chen & Ling-hua Meng. (2021) The double faced role of xanthine oxidoreductase in cancer. Acta Pharmacologica Sinica 43:7, pages 1623-1632.
Crossref
Crossref
A. A. Garanin, N. L. Novichkova & N. L. Novichkova. (2022) Prospects of anti-inflammatory and urate-lowering therapy of gout: A vector from the past to the future. Rheumatology Science and Practice 60:2, pages 205-213.
Crossref
Crossref
Pauline Braet, Giulia Vanessa Re Sartò, Marta Pirovano, Ben Sprangers & Laura Cosmai. (2022) Treatment of acute kidney injury in cancer patients. Clinical Kidney Journal 15:5, pages 873-884.
Crossref
Crossref
Shaunak Navalkissoor, Christos Toumpanakis, Martyn Caplin & Gopinath Gnanasegaran. (2022)
Treatment of neuroendocrine tumours with
177
Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their management
. Journal of Neuroendocrinology 34:4.
Crossref
Crossref
Ulrike Nitschke, Timo Behlendorf, Wolfgang Schütte & Petra Feyer. (2022) Onkologische Notfälle im BehandlungsalltagOncologic emergencies in everyday treatment. best practice onkologie 17:3, pages 78-90.
Crossref
Crossref
Patrizia Cioni, Edi Gabellieri, Barbara Campanini, Stefano Bettati & Samanta Raboni. (2022) Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications. Current Medicinal Chemistry 29:3, pages 411-452.
Crossref
Crossref
Marialaura Marchetti, Serena Faggiano & Andrea Mozzarelli. (2022) Enzyme Replacement Therapy for Genetic Disorders Associated with
Enzyme Deficiency. Current Medicinal Chemistry 29:3, pages 489-525.
Crossref
Crossref
Samet Yaman, Semih Başcı, Gökhan Turan, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Merih Kızıl Çakar & Fevzi Altuntaş. (2022) Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies. Clinical Lymphoma Myeloma and Leukemia 22:2, pages e71-e76.
Crossref
Crossref
Jan A. Stratmann. 2022. Therapie-Handbuch - Onkologie und Hämatologie. Therapie-Handbuch - Onkologie und Hämatologie
92
99
.
Giorgio Attinà, Raffaele Tepedino & Antonio Ruggiero. (2021) Acute Tumor Lysis Syndrome: A Metabolic Emergency in Cancer Patients. Biomedical and Pharmacology Journal 14:3, pages 1721-1729.
Crossref
Crossref
Li Wang, Xiaolin Li, Bin Zhao, Dan Mei, Jiandong Jiang & Jingli Duan. (2021) Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study. Frontiers in Pharmacology 12.
Crossref
Crossref
N. Kutsch & K. Fischer. (2021) 66/m mit chronisch lymphatischer Leukämie und akutem Nierenversagen unter Therapie mit Obinutuzumab und Venetoclax66/m—with chronic lymphocytic leukemia and acute renal failure under treatment with obinutuzumab and venetoclax. Der Internist 62:S4, pages 372-374.
Crossref
Crossref
Davide Agnoletti, Arrigo F.G. Cicero & Claudio Borghi. (2021) The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems. Cardiology Clinics 39:3, pages 365-376.
Crossref
Crossref
Grazielle Paz, Gisele De Amorim & Janaina Fernandes. (2021)
Metformin restores cisplatin cytotoxicity reduced by allantoin in CML
in vitro
. World Academy of Sciences Journal 3:5.
Crossref
Crossref
Yulistiani, Claudia Tiffany, I. Dewa Gede Ugrasena & Mariyatul Qibtiyah. (2021) Hydration effect on kidney function and serum electrolyte in children with tumor lysis syndrome (TLS) and risk of TLS. Journal of Basic and Clinical Physiology and Pharmacology 32:4, pages 603-609.
Crossref
Crossref
Alok Ranjan, Nisha Khanna, Vivek Ranjan & Ashwin Kumar. (2021) Follow-Up Study on Management of Tumour Lysis Syndrome with Single Low Fixed Dose (1.5 mg) of Rasburicase - A Tertiary Cancer Centre Experience from India. Journal of Evidence Based Medicine and Healthcare 8:25, pages 2149-2154.
Crossref
Crossref
Nazli ÖZTÜRK & Fatma ARIKAN. (2021) Tümör Lizis Sendromunda Hemşirelik YaklaşımıNursing Approach in Tumor Lysis Syndrome. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi 4:1, pages 113-122.
Crossref
Crossref
Laura Cosmai, Camillo Porta, Marina Foramitti, Valentina Perrone, Ludovica Mollica, Maurizio Gallieni & Giovambattista Capasso. (2021) Preventive strategies for acute kidney injury in cancer patients. Clinical Kidney Journal 14:1, pages 70-83.
Crossref
Crossref
Mitchell H. Rosner, Kenar D. Jhaveri, Blaithin A. McMahon & Mark A. Perazella. (2020) Onconephrology: The intersections between the kidney and cancer. CA: A Cancer Journal for Clinicians 71:1, pages 47-77.
Crossref
Crossref
Benjamin Garmezy, Jordan K. Schaefer, Jessica Mercer & Moshe Talpaz. (2021) A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management. Blood Reviews 45, pages 100691.
Crossref
Crossref
Winfried Alsdorf, Martin Sökler & Carsten Bokemeyer. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
3
.
Tonja Dirkx. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
579
591
.
Muthukumaran Jayachandran & Shen Qu. (2020) Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Medicinal Research Reviews 41:1, pages 616-629.
Crossref
Crossref
Myung Hyun Cho, Yo Han Ahn, Seon hee Lim, Ji Hyun Kim, Il-Soo Ha, Hae Il Cheong & Hee Gyung Kang. (2020) Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome. Pediatric Nephrology 35:11, pages 2183-2189.
Crossref
Crossref
Marta Skoczyńska, Małgorzata Chowaniec, Anna Szymczak, Anna Langner-Hetmańczuk, Beata Maciążek-Chyra & Piotr Wiland. (2020) Pathophysiology of hyperuricemia and its clinical significance – a narrative review. Rheumatology 58:5, pages 312-323.
Crossref
Crossref
Wiebke Wesemüller & Christian Taverna. (2020) Spontaneous Tumor Lysis Syndrome. Case Reports in Oncology 13:3, pages 1116-1124.
Crossref
Crossref
Mohsin Shah, Eva Rajha, Courtney DiNardo, Erin Muckey, William G. Wierda & Sai-Ching J. Yeung. (2020) Adverse Events of Novel Therapies for Hematologic Malignancies: What Emergency Physicians Should Know. Annals of Emergency Medicine 75:2, pages 264-286.
Crossref
Crossref
Joanna Matuszkiewicz-Rowinska & Jolanta Malyszko. (2020) Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress. Kidney and Blood Pressure Research 45:5, pages 645-660.
Crossref
Crossref
Peter Hau, Marcus Hentrich, Johannes Rieger & Ursula Vehling-Kaiser. 2020. Onkologische Erkrankungen in der Hausarztpraxis. Onkologische Erkrankungen in der Hausarztpraxis
159
187
.
Atul Kulkarni & Vandana Agarwal. 2020. ICU Protocols. ICU Protocols
89
101
.
O’Dene Lewis & Stephen M. Pastores. 2020. Oncologic Critical Care. Oncologic Critical Care
1119
1133
.
Thao-Tammy T. Ly & Elizabeth J. Winokur. (2019) Tumor Lysis Syndrome: A Practical Guide for Nurse Practitioners. The Journal for Nurse Practitioners 15:9, pages 636-639.
Crossref
Crossref
Saba Ghanbari-Ardestani, Sepideh Khojasteh-Band, Maryam Zaboli, Zahra Hassani, Mojtaba Mortezavi, Mohamad Mahani & Masoud Torkzadeh-Mahani. (2019) The effect of different percentages of triethanolammonium butyrate ionic liquid on the structure and activity of urate oxidase: Molecular docking, molecular dynamics simulation, and experimental study. Journal of Molecular Liquids 292, pages 111318.
Crossref
Crossref
Jose Manuel Calvo Villas. (2019) Síndrome de lisis tumoral. Medicina Clínica 152:10, pages 397-404.
Crossref
Crossref
Jose Manuel Calvo Villas. (2019) Tumour lysis syndrome. Medicina Clínica (English Edition) 152:10, pages 397-404.
Crossref
Crossref
Yu Toyoda, Tappei Takada & Hiroshi Suzuki. (2019) Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications. Frontiers in Pharmacology 10.
Crossref
Crossref
O’Dene Lewis & Stephen M. Pastores. 2019. Oncologic Critical Care. Oncologic Critical Care
1
15
.
Haileleul Micho, Yasin Mohammed, Daniel Hailu & Solomon Genet. (2018) Evaluation and characterization of tumor lysis syndrome before and after chemotherapy among pediatric oncology patients in Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. BMC Hematology 18:1.
Crossref
Crossref
Morné F. Kahts, Alan Davidson, Ann Van Eyssen, Peter Nourse, Mignon McCulloch & Marc Hendricks. (2018) A cost comparison of rasburicase versus dialysis in the management of children with acute leukaemia and lymphoma at a South African centre. South African Journal of Oncology 2.
Crossref
Crossref
April J. Bays & Kelly M. Foltz. 2018. Veterinary Technician's Manual for Small Animal Emergency and Critical Care. Veterinary Technician's Manual for Small Animal Emergency and Critical Care
191
222
.
Kathleen Stephanos & Lindsey Picard. (2018) Pediatric Oncologic Emergencies. Emergency Medicine Clinics of North America 36:3, pages 527-535.
Crossref
Crossref
G. von Amsberg. (2018) Onkologische Notfälle in der ChemotherapieOncological emergencies in chemotherapy. Der Urologe 57:5, pages 552-557.
Crossref
Crossref
Anda R. Gonciulea & Suzanne M. Jan de Beur. 2018. Endocrine and Metabolic Medical Emergencies. Endocrine and Metabolic Medical Emergencies
422
432
.
Mehdi Imani & Serveh Shahmohamadnejad. (2017) Recombinant production of Aspergillus Flavus uricase and investigation of its thermal stability in the presence of raffinose and lactose. 3 Biotech 7:3.
Crossref
Crossref